Four potential criteria for deciding when to use antidepressants or psychotherapy for unipolar depression: A literature review

References

• Druss BG, Rosenheck RA. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatr Serv 1999;50(2):214–8.
   PubMed Web of Science ®Google Scholar
• Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 1996;163:1411–7.
   Google Scholar
• Lyness JM, Heo M, Datto CJ, Ten Have TR, Katz IR, Drayer R, . Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Int Med 2006;144(7):496–504.
   PubMed Web of Science ®Google Scholar
• Nutt D. Anxiety and depression: Individual entiteis or two sides of the same coin? Int J Psychiatry Clin Pract 2004;8: 19–24.
   PubMed Web of Science ®Google Scholar
• Mykletun A, Bjerkeset O, Øverland S, Prince M, Dewey M, Stewart R. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry 2009;195: 118–25.
   PubMed Web of Science ®Google Scholar
• Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, . Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004;109(420):21–7.
   Google Scholar
• Kessler R, Berglund P, Borges G, Nock M, Wang P. Trends in suicide ideation, plans, gestures, and attempts in the United States. J Am Med Assoc 2005;293:2488–95.
   Web of Science ®Google Scholar
• Kessler R, McGonagle K, Shanyang Z, Nelson C, Hughes M, Eshleman S, . Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19.
   PubMed Web of Science ®Google Scholar
• Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386–92.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global burden of disease study. Lancet. 1997;349:1498–504.
   PubMed Web of Science ®Google Scholar
• WHO. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull WHO 2001;78:413–426.
   Web of Science ®Google Scholar
• APA. Diagnostic and Statistical manual of mental disorders. 4th. Text revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Hollon S, Thase M, Markowitz J. Treatment and prevention of depression. Psychol Sci Public Interest 2002; 2:39–77.
   Google Scholar
• Thase ME, Denko T. Pharmacotherapy of mood disorders. Annu Rev Clin Psychol 2008;4.
   PubMed Web of Science ®Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, . Antidepressant drug effects and depression severity: a patient-level meta-analysis. J Am Med Assoc 2010;303(1):47–53.
   PubMed Web of Science ®Google Scholar
• Kirsch I, Scoboria A, Moore T. Antidepressants and placebos: Secrets, revelations, and unanswered questions. Prevention Treat 2002;5(33):1–14.
   Google Scholar
• Moncrieff J, Kirsch I. Efficacy of antidepressants in adults. Br Med J 2005;331:155–7.
   PubMed Web of Science ®Google Scholar
• Moncrieff J, Wessely S, Hardy R. Active placebo versus antidepressants for depression (Review). The Cochrane Collaboration 2010;2010(1):1–28.
   Google Scholar
• Moller H-J. Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci 2008;258:451–5.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, Anderson G, van Oppen P. Psychology for depression in adults: A meta-analysis of comparative outcomes studies. J Consult Clin Psychol 2008; 76(6):909–22.
   PubMed Web of Science ®Google Scholar
• Schatzberg AF, Rush AJ, Arnow BA, Banks PLC, Blalock JA, Borian FE, . Chronic depression – medication (Nefazodone) of psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 2005;62:513–20.
   PubMed Web of Science ®Google Scholar
• Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, . Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry 2009; 66(11):1178–88.
   PubMed Web of Science ®Google Scholar
• Segal ZV, Pearson JL, Thase ME. Challenges in preventing relapse in major depression: Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression. J Affect Disord 2003;77: 97–108.
   PubMed Web of Science ®Google Scholar
• de Maat S, Dekker J, Schoevers R, de Jonge F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: A meta-analysis. Eur Psychiatry 2007; 22:1–8.
   PubMed Web of Science ®Google Scholar
• Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: A comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 2002; 159:1354–60.
   PubMed Web of Science ®Google Scholar
• Frank E, Novick D, Kupfer D. Antidepressants and psychotherapy: A clinical research review. Focus 2006;4:681–588.
   Google Scholar
• Friedman M, Detweller-Bedell J, Leventhal H, Home R, Keitner G, Miller I, . Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract 2006;11:47–68.
   Web of Science ®Google Scholar
• Parker G, Parker I, Brotchie H, Stuart S. Interpersonal psychotherapy for depression? The need to define its ecological niche. J Affect Disord 2006;95:1–11.
   PubMed Web of Science ®Google Scholar
• Elvins R, Green J. The conceptualization and measurement of therapeutic alliance: an empirical review. Clin Psychol Rev 2008;28(7):1167–87.
   PubMed Web of Science ®Google Scholar
• Lopez-Leon S, Janssens ACJW, Gonzalez-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, . Meta-analysis of genetic studies on major depressive disorder. Mol Psychiatry 2008;13:772–85.
   PubMed Web of Science ®Google Scholar
• Slotsky S, Glass D, Shea M, Pilkonis P, Collins J, Elkin I, . Patient predictors of response to psychotherapy and pharmacotherapy. Am J Psychiatry 1991;148:997–1008.
   PubMed Web of Science ®Google Scholar
• Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009;77(4): 775–87.
   PubMed Web of Science ®Google Scholar
• Rude S, Rehm L. Response to treatments for depression: the role of initial status on targeted cognitive and behavioral skills. Clin Psychol Rev 1991;11:493–514.
   Web of Science ®Google Scholar
• Leventhal AM, Rehm LP. The empirical status of melancholia: Implications for psychology. Clin Psychol Rev 2005;25: 25–44.
   PubMed Web of Science ®Google Scholar
• Clark L, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 1991;100:316–35.
   PubMed Web of Science ®Google Scholar
• Marcos T, Salamero M. Factor study of the Hamilton Ratings Scale for Depression and the Beck Melancholic Scale. Acta Psychiatr Scand 1990;82:178–81.
   PubMed Web of Science ®Google Scholar
• Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, . Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA 2009;106(9): 3543–8.
   PubMed Web of Science ®Google Scholar
• Fiocco AJ, Wan N, Weekes N, Pim H, Lupien SJ. Diurnal cycle of salivary cortisol in older adults men and women with subjective complaints of memory deficits and/or depressive symptoms: Relation to cognitive functioning. Stress 2006; 9(3):143–52.
   PubMed Web of Science ®Google Scholar
• Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005;67(Suppl 1):S26–8.
   Google Scholar
• Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol Bull 2004;130(4):601–30.
   PubMed Web of Science ®Google Scholar
• Thase ME, Howland RH. Biological processes in depression: An updated review and integration. Beckham EE, Leber WR. Handbook of depression. New York: Guilford; 1995. 213–79.
   Google Scholar
• Rush A, Giles DE, Schlesser MA, Orsulak P, Weissenburger J, Fulton CL, . Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psychiatry 1997;41:915–28.
   PubMed Web of Science ®Google Scholar
• Galynker II, Cai J, Ongsengg F, Finsetone H, Dutta E, Serseni D. Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 1998;39:608–12.
   PubMed Web of Science ®Google Scholar
• Shea M, Widiger T, Klein M. Comorbidity of personality disorders and depression: Implications for treatment. J Consult Clin Psychol 1992;60:857–68.
   PubMed Web of Science ®Google Scholar
• Mulder G. Personality pathology and treatment outcome in major depression: A review. Am J Psychiatry 2002;159: 359–71.
   PubMed Web of Science ®Google Scholar
• Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, . Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord 2009;117(3):174–9.
   PubMed Web of Science ®Google Scholar
• Fournier J, DeRubeis R, Shleton R, Gallop R, Amsterdam J, Hollon S. Antidepressant medications versus cognitive therapy in depressed paqtients with or without personality disorder. Br J Psychiatry 2008;192:124–9.
   PubMed Web of Science ®Google Scholar
• Downey G, Coyne JC. Children of depressed parents: An integrative review. Psychol Bull 1990;108(1):50–76.
   PubMed Web of Science ®Google Scholar
• Gershon ES, Hamovit J, Guroff J, Dibble E, Leckman JF, Sceery W, . A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982;39(10):1157–67.
   PubMed Web of Science ®Google Scholar
• Weissman M, Wickramratne P, Nomura Y, Warner V, Verdeli H, Pilowsky DJ, . Families at high and low risk for depression: A 3-generation study. Arch Gen Psychiatry 2005;62:29–36.
   PubMed Web of Science ®Google Scholar
• Wickramratne P, Weissman M. Onset of psychopathology in offspring by developmental phase and parental depression. J Am Acad Child Adolesc Psychiatry 1998;37(9):933–42.
   PubMed Web of Science ®Google Scholar
• Wickramaratne PJ, Warner V, Weissman G. Selecting early onset MDD probands for genetic studies: Results from a longitudinal high-risk study. Am J Med Genet Part B Neuropsychiatr Genet 2000;96:93–101.
   Web of Science ®Google Scholar
• Lieb R, Isensee B, Hofler M, Pfister H, Wittchen H-U. Parental major depression and the risk of depression and other mental disorders in offspring: A prospective-longitudinal community study. Arch Gen Psychiatry 2002;59:365–74.
   PubMed Web of Science ®Google Scholar
• Lesch KP. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 2004;29(3):174–84.
   PubMed Web of Science ®Google Scholar
• Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 2008;13:131–46.
   PubMed Web of Science ®Google Scholar
• Sullivan PF, de Geus EJC, Willemsen G, James MR, Smit JH, Zandbelt T, . Genome-wide association for major depression disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 2009;14:359–75.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Mason GF, Krystal JH. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 2000;14(1):23–45.
   PubMedGoogle Scholar
• Muller N, Schwartz MJ. The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Mol Psychiatry 2007;12:988–1000.
   PubMed Web of Science ®Google Scholar
• Choudary P, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MF, . Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005;102:15653–8.
   PubMed Web of Science ®Google Scholar
• López León S, Croes EA, Sayed-Tabatabaei FA, Claes S, Broeckhoven CV, van Duijn CM. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis. Biol Psychiatry 2005;57(9):999–1003.
   PubMed Web of Science ®Google Scholar
• Routledge C, Middlemiss D. The 5-HT hypothesis of depression. Mol Psychiatry 1996;1:437.
   PubMed Web of Science ®Google Scholar
• Dannlowski U, Ohrmann P, Bauer J, Kugel H, Baune BT, Hohoff C, . Serotonergic genes modulates amygdala activity in major depression. Genes Brain Behav 2007;6: 672–6.
   PubMed Web of Science ®Google Scholar
• Smolka MN, Buhler M, Schumann G, Klein S, Hu XZ, Moayer M, . Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 2007;12(3):307–17.
   PubMed Web of Science ®Google Scholar
• Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, . Serotonin transporter genotype (5-HTTLPR): Effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 2007;61(8):1011–4.
   PubMed Web of Science ®Google Scholar
• Segers O. Genetic determinants of cortisol responss to daily life stressors [Dissertation]. Hasselt: University of Hasselt; 2007.
   Google Scholar
• Yuan T-F. Depression: interrupted genetic seesaws in the hypothalamus. Mol Psychiatry 2008;13:830.
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Greden JF, Feinberg M, Lohr N, James NM, Steiner M, . Neuroendocrine evaluation of depression in borderline patients. Psychiatr Clin N Am 1981;4(1):89–99.
   PubMed Web of Science ®Google Scholar
• Holsboer F. Therapeutics for depression and anxiety disorders. Drug Discoveries Today: Therapeutic Strategies 2004; 1(1):105–9.
   Google Scholar
• Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin N Am 1998;21:293–307.
   PubMed Web of Science ®Google Scholar
• Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Juhasz G, . New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol Psychiatry 2008;64:498–504.
   PubMed Web of Science ®Google Scholar
• Dong C, Wong ML, Licinio J. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Mol Psychiatry 2009;14(12):1105–18.
   PubMed Web of Science ®Google Scholar
• Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, . Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 2008;13(7):709–16.
   PubMed Web of Science ®Google Scholar
• Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, . Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003;301(5631):386–9.
   PubMed Web of Science ®Google Scholar
• Eley TC, Sugden K, Gregory AM, Sham P, McGuffin P, Plomin R, Craig, IW. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004;9:908–915.
   PubMed Web of Science ®Google Scholar
• Uher R. The implications of gene-environment interactions in depression: will cause inform cure? Mol Psychiatry 2008; 13:1070–8.
   PubMed Web of Science ®Google Scholar
• Uher R, McGuffin P. The moderation by the seritonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010;15:18–22.
   PubMed Web of Science ®Google Scholar
• Kendler K, Kuhn J, Vittum J, Prescott C, Riley B. The interaction of sterssful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Arch Gen Psychiatry 2005;62:529–35.
   PubMed Web of Science ®Google Scholar
• Li Q, Wichems C, Heils A, Van de Dar L, Lesch K-P, Murphy D. Reduction of 5-HT1A binding sites in 5-HT transporter knockout mice. J Pharmacol Exp Ther 1999; 291:999–1007.
   PubMed Web of Science ®Google Scholar
• Barr C, Newman T, Shannon C, Parker C, Dvoskin R, Becker M, . Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry 2004;55:733–8.
   PubMed Web of Science ®Google Scholar
• Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus 2006;16:233–8.
   PubMed Web of Science ®Google Scholar
• Hettema JM, An SS, Bukszar J, van den Oord EJ, Kendler KS, Chen X. Association between glutamic and decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 2006;11(8):752–62.
   PubMed Web of Science ®Google Scholar
• Bear M, Connors B, Paradiso M. Neuroscience: Exploring the brain. 3rd. Baltimore, MD: Lippincott, Williams & Wilkins; 2007.
   Google Scholar
• McCullough JP. Treatment for depression: Cognitive behavioral analysis system of psychotherapy. New York: Guilford; 2000.
   Google Scholar
• de Maat SM, Dekker J, Schoevers RA, de Jonghe F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: A meta-analysis. Eur Psychiatry 2007; 22:1–8.
   PubMed Web of Science ®Google Scholar
• Thase ME, Friedman ES. Is psychotherapy an effective treatment for melancholia and severe depressive states? J Affect Disord 1999;54:1–19.
   PubMed Web of Science ®Google Scholar
• DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, . Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409–16.
   PubMed Web of Science ®Google Scholar
• Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK, . A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychology 1996; 64(2):295–304.
   PubMed Web of Science ®Google Scholar
• Jacobson NS, Gortner ET. Can depression be de-medicalized in the 21st century: scientific revolutions, counter-revolutions and the magnetic field of normal science. Behav Res Ther 2000;38(2):103–17.
   PubMed Web of Science ®Google Scholar
• Weisz JR, Southam-Gerow MA, Gordis EB, Connor-Smith JK, Chu BC, Langer DA, . Cognitive-behavioral therapy versus usual clinical care for youth depression: An initial test of transportability to community clinics and clinicians. J Consult Clin Psychol 2009;77(3):383–96.
   PubMed Web of Science ®Google Scholar
• Oken BS. Placebo effects: clinical aspects and neurobiology. Brain 2008;131(11):2812–23
   PubMedGoogle Scholar
• Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, . Chronic forms of major depression are still undertreated in the 21st centry: Systematic assessment of 801 patients presenting for treatment. J Affect Disord 2008;110:55–61.
   PubMed Web of Science ®Google Scholar